Market Overview

AbbVie Shares Moving Higher On Guidance Announcement


AbbVie  (NYSE: ABBV) shares are moving higher in Monday’s pre-market session after the company raised guidance.

Full year guidance is now expected between $3.06 and $3.16 versus $3.00 to $3.10 announced at the end of January. This is a two percent increase from the midpoint. The company also announced that the guidance does not include any potential earnings from the U.S. launch of its hepatitis C therapy that is under accelerated review by the FDA.

Shares of AbbVie were last trading at $54.49, up 2.23 percent since Friday’s close.

Posted-In: News Guidance


Related Articles (ABBV)

View Comments and Join the Discussion!
Need corporate guidance data?
Click here to see licensing options.
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Morgan Stanley Has Positive Outlook On Finish Line

Benzinga's Top #PreMarket Losers